Alpha Teknova (TKNO) Cost of Revenue (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Cost of Revenue came in at $7.3 million in Q1 2026, up 7.44% year-on-year from $6.8 million in Q1 2025, and up 8.2% on a QoQ basis from $6.7 million in Q4 2025.
Alpha Teknova (TKNO) Cost of Revenue (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Cost of Revenue data on file, last reported at $7.3 million in Q1 2026.
- On a quarterly basis, Cost of Revenue rose 7.44% year-over-year to $7.3 million in Q1 2026; TTM through Mar 2026 was $27.6 million, a 8.73% decrease from a year earlier, with the FY2025 full-year figure at $27.1 million, down 11.26% from the prior year.
- Cost of Revenue for Q1 2026 stood at $7.3 million, up from $6.7 million in the prior quarter.
- Over the last five years, Cost of Revenue for TKNO reached as high as $9.5 million in Q3 2024 and fell as low as $5.8 million in Q4 2022.
- Historically, Cost of Revenue has averaged $6.8 million across 5 years, with a median of $6.7 million in 2023.
- Across the five-year window, Cost of Revenue soared 43.05% in 2022 and retreated 23.59% in 2025, its largest moves.
- Year by year, Cost of Revenue stood at $5.8 million in 2022, then rose by 12.99% to $6.5 million in 2023, then advanced by 9.26% to $7.1 million in 2024, then fell by 5.56% to $6.7 million in 2025, then grew by 8.2% to $7.3 million in 2026.
- Per Business Quant data, the three most recent Cost of Revenue figures were $7.3 million in Q1 2026, $6.7 million in Q4 2025, and $7.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Alpha Teknova | 258.92 Mn | 241.13 Mn | 3.78 Mn | 7.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.29 Mn |
| Mar 31, 2026 | 7.29 Mn |
| Dec 31, 2025 | 6.74 Mn |
| Dec 31, 2025 | 6.74 Mn |
| Sep 30, 2025 | 7.25 Mn |
| Sep 30, 2025 | 7.25 Mn |
| Jun 30, 2025 | 6.30 Mn |
| Jun 30, 2025 | 6.30 Mn |
| Mar 31, 2025 | 6.79 Mn |
| Mar 31, 2025 | 6.79 Mn |
| Dec 31, 2024 | 7.14 Mn |
| Dec 31, 2024 | 7.14 Mn |
| Sep 30, 2024 | 9.49 Mn |
| Sep 30, 2024 | 9.49 Mn |
| Jun 30, 2024 | 6.81 Mn |
| Jun 30, 2024 | 6.81 Mn |
| Mar 31, 2024 | 7.08 Mn |
| Mar 31, 2024 | 7.08 Mn |
| Dec 31, 2023 | 6.53 Mn |
| Dec 31, 2023 | 6.53 Mn |